The Addition of Computer-Aided Detection (CADe) to Texture and Color Enhancement Imaging (TXI) Does Not Improve Adenoma Detection Rate During Colonoscopy: A Prospective Study - Scorecard - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Incorporating Computer-Aided Detection (CADe) with Texture and Color Enhancement Imaging (TXI) Does Not Enhance Adenoma Detection Rates in Colonoscopy: A Prospective Investigation
Clinical Scorecard: Incorporating Computer-Aided Detection (CADe) with Texture and Color Enhancement Imaging (TXI) Does Not Enhance Adenoma Detection Rates in Colonoscopy: A Prospective Investigation
At a Glance
Category
Detail
Condition
Colorectal cancer prevention
Key Mechanisms
Use of CADe and TXI to enhance polyp detection during colonoscopy
Target Population
Adults aged 18–85 undergoing colonoscopy
Care Setting
Tertiary care centers
Key Highlights
TXI improved adenoma detection rate (ADR) from 40.99% to 54.6%
CADe systems demonstrated a 20% increase in ADR compared to routine colonoscopy
Combination of CADe and TXI did not yield additional gains in ADR
High rates of false positives associated with CADe may lead to proceduralist fatigue
Enhanced detection was most pronounced for flat and right-sided lesions
Guideline-Based Recommendations
Diagnosis
Colonoscopy with high-definition imaging is recommended for polyp detection
Management
Polyp surveillance according to Australian National Bowel Cancer Screening Program guidelines
Monitoring & Follow-up
Monitor polyp detection rates and proceduralist performance
Risks
Potential for increased proceduralist fatigue and prolonged withdrawal times due to CADe false positives
Patient & Prescribing Data
Adults aged 18–85 with no significant comorbidities
TXI and CADe are adjuncts to standard colonoscopy but may not significantly enhance detection rates
Clinical Best Practices
Ensure adequate bowel preparation (BBPS ≥ 6) for colonoscopy
Utilize high-definition colonoscopes for improved visualization
Document polyp characteristics according to the Paris classification
The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.
